These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3927693)

  • 1. Cost containment in medicine: why cardiology?
    Harrison DC
    Am J Cardiol; 1985 Aug; 56(5):10C-15C. PubMed ID: 3927693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
    Vaitkus PT
    Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluating the first German diagnosis-related groups (G-DRG) in cardiological patients: problems in the correct medical and economic grouping].
    Reinecke H; Bunzemeier H; Fürstenberg T; Rothenburger M; Böcker D; Scheld HH; Breithardt G; Roeder N
    Z Kardiol; 2003 Jul; 92(7):581-94. PubMed ID: 12883843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost containment (DRGs): a new source for litigation?
    Zaremski M; Rehm J
    Health Matrix; 1985; 3(2):24-7. PubMed ID: 10311246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social policy and professional self-interest: physician responses to DRGs.
    Notman M; Howe KR; Rittenberg W; Bridgham R; Holmes MM; Rovner DR
    Soc Sci Med; 1987; 25(12):1259-67. PubMed ID: 3124271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear cardiology in hospital-based practice.
    Gibbons R
    J Nucl Cardiol; 1997; 4(2 Pt 2):S179-83. PubMed ID: 9115082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic outcomes assessment in nuclear cardiology.
    Shaw LJ; Miller DD; Berman DS; Hachamovitch R
    Q J Nucl Med; 2000 Jun; 44(2):138-52. PubMed ID: 10967624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital costs, resource characteristics, and the dynamics of death for hospitalized patients in cardiology Diagnosis-Related Groups.
    Muñoz E; Chalfin D; Birnbaum E; Mulloy K; Cohen J; Wise L
    Heart Lung; 1989 Mar; 18(2):164-71. PubMed ID: 2494133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory cost and utilization containment.
    Steiner JW; Root JM; White DC
    Clin Lab Manage Rev; 1991; 5(5):372-4, 376, 378-84. PubMed ID: 10113716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proprietary hospitals in cost containment.
    Jones DA
    Am J Cardiol; 1985 Aug; 56(5):40C-42C. PubMed ID: 3927697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Payment systems and considerations of case mix--are diagnosis-related groups applicable in Japan?
    Kawabuchi K
    Pharmacoeconomics; 2000; 18 Suppl 1():95-110. PubMed ID: 11151315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and performance of different DRG classification systems for neonatal medicine.
    Muldoon JH
    Pediatrics; 1999 Jan; 103(1 Suppl E):302-18. PubMed ID: 9917473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in patient routine costliness in U.S. psychiatric facilities.
    Cromwell J; Drozd EM; Gage B; Maier J; Richter E; Goldman HH
    J Ment Health Policy Econ; 2005 Mar; 8(1):15-28. PubMed ID: 15870482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of hospital case mix, cost, and payment differences for Medicare, Medicaid, and Blue Cross Plan patients using DRGs.
    Martin SG; Frick AP; Shwartz M
    Inquiry; 1984; 21(4):369-79. PubMed ID: 6240468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost of diagnostic and therapeutic hemodynamic procedures: comparison with DRG reimbursement].
    Varani E; Balducelli M; Vecchi G; Maresta A
    Ital Heart J Suppl; 2001 Jun; 2(6):647-52. PubMed ID: 11460839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of single-vessel and multivessel coronary drug-eluting stenting: comparison to the DRG funding level.
    Varani E; Balducelli M; Gatti C; Tesselli MR; Vecchi G; Maresta A
    Ital Heart J; 2005 Jan; 6(1):52-8. PubMed ID: 15773274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Payment of hospital cardiac services.
    Unger WJ
    Hosp Technol Ser; 1991; 10(26):1-148. PubMed ID: 10115896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hard choices that we must make.
    Harrison DC; Lippincott JR
    Consultant; 1988 Mar; 28(3):82-3, 87-8, 91. PubMed ID: 10318054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.